Adam Craig, EVP, Development & CMO at Viracta Therapeutics, holds 0.00 shares in CTI BioPharma (Ticker: CTIC), holds 23.45K shares in Viracta Therapeutics (Ticker: VIRX).

See the Hottest Stocks Based on Insider Trading >

Adam Craig
Viracta Therapeutics (VIRX)
EVP, Development & CMO

Not Ranked

Ranked #17,141 out of 98,624 Corporate Insiders

Adam Craig has not reported sufficient informative transactions and therefore cannot be ranked.

Time Frame

1 Year

Compare to

No Benchmark

How are Insiders Ranked?

Insider Holdings

100.00%

VIRX

A breakdown of Adam Craig's holdings

See the Top Stocks by Insiders

Insider Roles

Viracta Therapeutics
(VIRX)

EVP, Development & CMO

Roles that Adam Craig holds in companies

See the Top Corporate Insiders

Most Profitable Insider Trade

Stock:

CTI BioPharma
(CTIC)

Rating:Informative Buy

Date:Dec 02, 2021 - Dec 02, 2022

Return:+315.90%

The most profitable trade made by Adam Craig

See the Latest Stocks Traded by Insiders

Adam Craig's Trading History

VIRX

Viracta Therapeutics

Mar 02, 2015

EVP, Development & CMO

Uninformative Buy

―

$19.42K

CTIC

CTI BioPharma

Jun 26, 2023

―

Uninformative Sell

286.38K

$0.00

List of latest transactions for each holding click on a transaction to see Adam Craig's performance on stock

See All Insider Trading from Today

Adam Craig insider profile FAQ

What is the percentage of profitable transactions made by Adam Craig?

The percentage of profitable transactions made by Adam Craig is ―.

What is the average return per transaction made by Adam Craig?

The average return per transaction made by Adam Craig is ―.

What stocks does Adam Craig hold?

Adam Craig holds: VIRX, CTIC stocks.

What was Adam Craig’s latest transaction?

Adam Craig latest transaction was an Uninformative Sell of $286.38K.

What was Adam Craig's most profitable transaction?

Adam Craig’s most profitable transaction was an Informative Buy of CTIC stock on December 2, 2021. The return on the trade was 315.90%.

What is Adam Craig's role in Viracta Therapeutics?

Adam Craig's role in Viracta Therapeutics is EVP, Development & CMO.

How can I follow the stock ratings of top corporate insiders?

Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

Adam Craig Insider Profile

Adam Craig Viracta Therapeutics (VIRX)EVP, Development & CMO